Evidence map›Paper›PMID 30230400›Full record

ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2019

Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis.

Kristin P O'Grady, Adrienne N Dula, Bailey D Lyttle, Lindsey M Thompson, Benjamin N Conrad, Bailey A Box, Lydia J McKeithan, Siddharama Pawate, Francesca Bagnato, Bennett A Landman and 2 more

Open access · greenAbstract read
In one paragraph

Article in Multiple sclerosis (Houndmills, Basingstoke, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Quantification of Tryptophan and NADMagnetic resonance in medicine · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Mapping hippocampal glutamate in healthy aging withFrontiers in aging neuroscience · 2024
    Article
  9. Biogenic Imaging Contrast Agents.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Glutamine antagonism attenuates physical and cognitive deficits in a model of MS.Neurology(R) neuroimmunology & neuroinflammation · 2019
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Kristin P O'GradyVanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-4550-2026
Adrienne N DulaDepartment of Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
Bailey D LyttleVanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA.
Lindsey M ThompsonVanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA.
Benjamin N ConradNeuroscience Graduate Program, Vanderbilt Brain Institute, Vanderbilt University Medical Center, Nashville, TN, USA.
Bailey A BoxVanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA.
Lydia J McKeithanVanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0003-0348-7144
Siddharama PawateVanderbilt Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Francesca BagnatoNeuroimaging Unit, Neuroimmunology Division, Vanderbilt Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
Bennett A LandmanVanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA/Department of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, TN, USA/Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA/Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Paul NewhouseDepartment of Psychiatry and Behavioral Sciences, Center for Cognitive Medicine, Vanderbilt University Medical Center, Nashville, TN, USA/Veterans Affairs Tennessee Valley Healthcare System Geriatric Research, Education, and Clinical Center (VA TVHS GRECC), Nashville, TN, USA.
Seth A SmithVanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA/Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA/Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Vanderbilt University Medical Center · USThe University of Texas at Austin · USVA Tennessee Valley Healthcare System · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Postdoctoral Training in Biomedical MRI and MRST32EB001628 · NIBIB · VANDERBILT UNIVERSITY MEDICAL CENTER · PI John C Gore · 2003 to 2026
$7.0M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)KL2TR000446 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$2.8M
Microstructural Characterization of the Optic Nerve in Optic NeuritisR01EY023240 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SMITH, SETH A · 2014 to 2017
$1.0M
Institutional Predoctoral Training Program in Biomedical Imaging ScienceT32EB014841 · NIBIB · VANDERBILT UNIVERSITY · PI GORE, JOHN C · 2013 to 2017
$771k
In Vivo Macromolecular and Protein-Based MRI in the Spinal Cord of MS PatientsR21NS087465 · NINDS · VANDERBILT UNIVERSITY · PI SMITH, SETH A · 2014 to 2015
$431k
Glutamate-Sensitive, Quantitative MRI in MS: Application to Cognitive ImpairmentF32NS101788 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI O'GRADY, KRISTIN POOLE · 2017 to 2018
$86k
NCATS NIH HHS KL2 TR000446NCRR NIH HHS UL1 RR024975NEI NIH HHS R01 EY023240NIBIB NIH HHS T32 EB001628NIBIB NIH HHS T32 EB014841NINDS NIH HHS F32 NS101788NINDS NIH HHS R21 NS087465
6 · The paper itself

Abstract

backgroundCognitive impairment (CI) profoundly impacts quality of life for patients with multiple sclerosis (MS). Dysfunctional regulation of glutamate in gray matter (GM) has been implicated in the pathogenesis of MS by post-mortem pathological studies and in CI by in vivo magnetic resonance spectroscopy, yet GM pathology is subtle and difficult to detect using conventional T

objectiveTo study cortical GM pathology related to CI in MS using glutamate-sensitive chemical exchange saturation transfer (GluCEST) MRI at 7.0 Tesla (7T).

methodsA total of 20 patients with relapsing-remitting MS and 20 healthy controls underwent cognitive testing, anatomical imaging, and GluCEST imaging. Glutamate-sensitive image contrast was quantified for cortical GM, compared between cohorts, and correlated with clinical measures of CI. RESULTS AND

conclusionGlutamate-sensitive contrast was significantly increased in the prefrontal cortex of MS patients with accumulated disability (

Indexed as

AdultCerebral CortexCognitive DysfunctionFemaleGlutamic AcidGray MatterHumansMagnetic Resonance ImagingMaleMiddle AgedMultiple SclerosisWhite MatterGlutamic Acidcognitive dysfunctionglutamategray mattermagnetic resonance imagingMultiple sclerosisprefrontal cortex

Identifiers

PMID30230400
PMCPMC6424643
OpenAlexW2889955935

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.